185 related articles for article (PubMed ID: 32653009)
1. Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases.
Papa R; Natoli V; Caorsi R; Minoia F; Gattorno M; Ravelli A
Pediatr Rheumatol Online J; 2020 Jul; 18(1):56. PubMed ID: 32653009
[TBL] [Abstract][Full Text] [Related]
2. Convergent pathways of the hyperferritinemic syndromes.
Schulert GS; Canna SW
Int Immunol; 2018 Apr; 30(5):195-203. PubMed ID: 29420734
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome in pediatrics.
Alongi A; Naddei R; De Miglio L; Natoli V; Ravelli A
Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():13-15. PubMed ID: 32017214
[TBL] [Abstract][Full Text] [Related]
4. Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis.
Fan Z; Kernan KF; Qin Y; Canna S; Berg RA; Wessel D; Pollack MM; Meert K; Hall M; Newth C; Lin JC; Doctor A; Shanley T; Cornell T; Harrison RE; Zuppa AF; Sward K; Dean JM; Park HJ; Carcillo JA
Crit Care; 2023 Sep; 27(1):347. PubMed ID: 37674218
[TBL] [Abstract][Full Text] [Related]
5. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
[TBL] [Abstract][Full Text] [Related]
6. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
[TBL] [Abstract][Full Text] [Related]
7. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
[TBL] [Abstract][Full Text] [Related]
8. Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.
Moling O; Piccin A; Tauber M; Marinello P; Canova M; Casini M; Negri G; Raffeiner B; Binazzi R; Gandini L; Vecchiato C; Rimenti G; Billio A
J Med Case Rep; 2016 Sep; 10(1):254. PubMed ID: 27634631
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome in the era of biologic therapy.
Grom AA; Horne A; De Benedetti F
Nat Rev Rheumatol; 2016 May; 12(5):259-68. PubMed ID: 27009539
[TBL] [Abstract][Full Text] [Related]
11. Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
Banse C; Vittecoq O; Benhamou Y; Gauthier-Prieur M; Lequerré T; Lévesque H
Joint Bone Spine; 2013 Dec; 80(6):653-5. PubMed ID: 23751410
[TBL] [Abstract][Full Text] [Related]
12. Variations in Macrophage Activation Syndrome-associated Cardiac Diseases: A Report on Two Cases.
Lin N; Xu L; Dai Q
Iran J Immunol; 2023 Mar; 20(1):135-143. PubMed ID: 36934324
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.
Weiss ES; Girard-Guyonvarc'h C; Holzinger D; de Jesus AA; Tariq Z; Picarsic J; Schiffrin EJ; Foell D; Grom AA; Ammann S; Ehl S; Hoshino T; Goldbach-Mansky R; Gabay C; Canna SW
Blood; 2018 Mar; 131(13):1442-1455. PubMed ID: 29326099
[TBL] [Abstract][Full Text] [Related]
14. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
15. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
Klocperk A; Parackova Z; Dissou J; Malcova H; Pavlicek P; Vymazal T; Dolezalova P; Sediva A
Front Immunol; 2020; 11():1665. PubMed ID: 32719688
[TBL] [Abstract][Full Text] [Related]
17. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome.
Valade S; Mariotte E; Azoulay E
Crit Care Clin; 2020 Apr; 36(2):415-426. PubMed ID: 32172822
[TBL] [Abstract][Full Text] [Related]
18. Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment.
Larroche C
Joint Bone Spine; 2012 Jul; 79(4):356-61. PubMed ID: 22464018
[TBL] [Abstract][Full Text] [Related]
19. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
Ruscitti P; Di Cola I; Di Muzio C; Italiano N; Ursini F; Giacomelli R; Cipriani P
Autoimmun Rev; 2022 Jul; 21(7):103114. PubMed ID: 35595050
[TBL] [Abstract][Full Text] [Related]
20. Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome - Successful use of PET- CT and Anakinra in its diagnosis and treatment.
Tayer-Shifman OE; Ben-Chetrit E
Mod Rheumatol; 2015; 25(6):954-7. PubMed ID: 24252009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
